The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Gut Microbiota and Complications of Type-2 Diabetes
Open accessAbstract
The gut microbiota has been linked to the emergence of obesity, metabolic syndrome and the onset of type 2 diabetes through decreased glucose tolerance and insulin resistance. Uncontrolled diabetes can lead to serious health consequences such as impaired kidney function, blindness, stroke, myocardial infarction and lower limb amputation. Despite a variety of treatments currently available, cases of diabetes and resulting complications are on the rise. One promising new approach to diabetes focuses on modulating the gut microbiota with probiotics, prebiotics, synbiotics and fecal microbial transplantation. Differences in gut microbiota composition have been observed in preclinical animal models as well as patients with type 2 diabetes and complications such as diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, cerebrovascular disease, coronary heart disease and peripheral artery disease compared to healthy controls. Severity of gut microbiota dysbiosis was associated with disease severity and restoration with probiotic administration in animal models and human patients has been associated with improvement of symptoms and disease progression. Characterizing the gut microbiota dysbiosis in different diseases and determining a causal relationship between the gut microbiota and disease can be beneficial in formulating therapeutic interventions for type 2 diabetes and associated complications. In this review, we present the most important findings regarding the role of the gut microbiota in type 2 diabetes and chronic complications as well as their underlying mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Asemi, Z., Khorrami-Rad, A., Alizadeh, S.-A., Shakeri, H., & Esmaillzadeh, A. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2013.05.015 · Cited by 190
RetractedKhalili, L., Alipour, B., Jafarabadi, M. A., Hassanalilou, T., Abbasi, M. M., & Faraji, I. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0400-7 · Cited by 61
RetractedSaeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61953-4 · Cited by 3,899
The impact of the gut microbiota on human health: an integrative view
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012) · Cell · doi:10.1016/j.cell.2012.01.035 · Cited by 3,710
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Preventing Foot Ulcers in Patients With Diabetes
Singh, N. (2005) · JAMA · doi:10.1001/jama.293.2.217 · Cited by 3,097
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
(2015) · PubMed Central · Cited by 2,540
Depommier, C., Everard, A., Druart, C., Plovier, H., Van Hul, M., Vieira-Silva, S., Falony, G., Raes, J., Maiter, D., Delzenne, N. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0495-2 · Cited by 2,357
The gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302 · cited 1×
“This can lead to the emergence of obesity [5], metabolic syndrome and the onset of type 2 diabetes [6,7] through decreased glucose tolerance and insulin resistance [8].”
BackgroundSuperoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling
Wang, Y., Branicky, R., Noë, A., & Hekimi, S. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708007 · Cited by 2,182
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
Diabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839
Epidemiology of Peripheral Artery Disease
Criqui, M. H., & Aboyans, V. (2015) · Circulation Research · doi:10.1161/circresaha.116.303849 · Cited by 1,785
Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Lee, R., Wong, T. Y., & Sabanayagam, C. (2015) · Eye and Vision · doi:10.1186/s40662-015-0026-2 · Cited by 1,569
Symptomatic atherosclerosis is associated with an altered gut metagenome
Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., & Nielsen, J. (2012) · Nature Communications · doi:10.1038/ncomms2266 · Cited by 1,371 · cited 3×
“For example, patients with coronary artery disease showed increases in Collinsella bacteria [94], mature lactobacilli [110], EscherichiaShigella [111], Enterococcus [111] and the ratio of Firmicutes to Bacteroides [112].”
Jones, B. V., Begley, M., Hill, C., Gahan, C. G. M., & Marchesi, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804437105 · Cited by 1,098
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072
Towards the human intestinal microbiota phylogenetic core
Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J., Ugarte, E., Muñoz‐Tamayo, R., Paslier, D. L. E., Nalin, R., et al. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01982.x · Cited by 927 · cited 4×
“A comparison of the gut microbiota in patients with diabetic neuropathy, patients with diabetes without diabetic neuropathy and healthy individuals showed an increase in Firmicutes and Actinobacteria as well as a decrease in Bacteroidetes in patients with diabetic nephropathy when compared to patients with diabetes wi…”
BackgroundInfluentialDiabetic Kidney Disease: A Report From an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 890
Probiotic yogurt improves antioxidant status in type 2 diabetic patients
Ejtahed, H. S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., & Mofid, V. (2012) · Nutrition · doi:10.1016/j.nut.2011.08.013 · Cited by 683
Yin, J., Liao, S., He, Y., Wang, S., Xia, G., Liu, F., Zhu, J., You, C., Chen, Q., Zhou, L., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002699 · Cited by 669
The role of the gut microbiome in the healthy adult status
D’Argenio, V., & Salvatore, F. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.003 · Cited by 492
Mechanism of diabetic neuropathy: Where are we now and where to go?
Yagihashi, S., Mizukami, H., & Sugimoto, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00070.x · Cited by 488
Microbial modulation of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.149 · Cited by 440
Long-Term Complications and Mortality in Young-Onset Diabetes
Constantino, M. I., Molyneaux, L., Limacher-Gisler, F., Al-Saeed, A., Luo, C., Wu, T., Twigg, S. M., Yue, D. K., & Wong, J. (2013) · Diabetes Care · doi:10.2337/dc12-2455 · Cited by 423 · cited 1×
“The presence of these complications also leads to an overall decline in quality of life and an increase in mortality rate [19].”
BackgroundEslamparast, T., Poustchi, H., Zamani, F., Sharafkhah, M., Malekzadeh, R., & Hekmatdoost, A. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.068890 · Cited by 405
Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target
Ramezani, A., Massy, Z. A., Meijers, B., Evenepoel, P., Vanholder, R., & Raj, D. S. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.09.027 · Cited by 394
Asemi, Z., Zare, Z., Shakeri, H., Sabihi, S.-S., & Esmaillzadeh, A. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000349922 · Cited by 392
Tonucci, L. B., Olbrich dos Santos, K. M., Licursi de Oliveira, L., Rocha Ribeiro, S. M., & Duarte Martino, H. S. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2015.11.011 · Cited by 381
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial
Rossi, M., Johnson, D. W., Morrison, M., Pascoe, E. M., Coombes, J. S., Forbes, J. M., Szeto, C.-C., McWhinney, B. C., Ungerer, J. P. J., & Campbell, K. L. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05240515 · Cited by 376
Vinik, A. I., Nevoret, M.-L., Casellini, C., & Parson, H. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.06.001 · Cited by 366
Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers
Naruszewicz, M., Johansson, M.-L., Zapolska-Downar, D., & Bukowska, H. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.6.1249 · Cited by 366
Beli, E., Yan, Y., Moldovan, L., Vieira, C. P., Gao, R., Duan, Y., Prasad, R., Bhatwadekar, A., White, F. A., Townsend, S. D., et al. (2018) · Diabetes · doi:10.2337/db18-0158 · Cited by 365
Oxidative stress in early diabetic nephropathy: fueling the fire
Singh, D. K., Winocour, P., & Farrington, K. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.212 · Cited by 353
Andreasen, A. S., Larsen, N., Pedersen-Skovsgaard, T., Berg, R. M. G., Møller, K., Svendsen, K. D., Jakobsen, M., & Pedersen, B. K. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510002874 · Cited by 347
Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
Bader, M. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105610 · Cited by 345
Intestinal microbiota determine severity of myocardial infarction in rats
Lam, V., Su, J., Koprowski, S., Hsu, A., Tweddell, J. S., Rafiee, P., Gross, G. J., Salzman, N. H., & Baker, J. E. (2012) · The FASEB Journal · doi:10.1096/fj.11-197921 · Cited by 340
Yamashiro, K., Tanaka, R., Urabe, T., Ueno, Y., Yamashiro, Y., Nomoto, K., Takahashi, T., Tsuji, H., Asahara, T., & Hattori, N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171521 · Cited by 314
Haghikia, A., Li, X. S., Liman, T. G., Bledau, N., Schmidt, D., Zimmermann, F., Kränkel, N., Widera, C., Sonnenschein, K., Haghikia, A., et al. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311023 · Cited by 311
Koh, A., & Bäckhed, F. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.005 · Cited by 309
Kieffer, D. A., Piccolo, B. D., Vaziri, N. D., Liu, S., Lau, W. L., Khazaeli, M., Nazertehrani, S., Moore, M. E., Marco, M. L., Martin, R. J., et al. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00513.2015 · Cited by 308
Laitinen, K., Poussa, T., Isolauri, E., & the Nutrition, A. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508111461 · Cited by 308
Rajkumar, H., Mahmood, N., Kumar, M., Varikuti, S. R., Challa, H. R., & Myakala, S. P. (2014) · Mediators of Inflammation · doi:10.1155/2014/348959 · Cited by 301
Risk Factors for Myocardial Infarction Case Fatality and Stroke Case Fatality in Type 2 Diabetes
Stevens, R. J., Coleman, R. L., Adler, A. I., Stratton, I. M., Matthews, D. R., & Holman, R. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.201 · Cited by 295
Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD
Matijašić, M., Meštrović, T., Čipčić Paljetak, H., Perić, M., Barešić, A., & Verbanac, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082668 · Cited by 284
Change of intestinal microbiota in cerebral ischemic stroke patients
Li, N., Wang, X., Sun, C., Wu, X., Lu, M., Si, Y., Ye, X., Wang, T., Yu, X., Zhao, X., et al. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1552-1 · Cited by 269
Obesity changes the human gut mycobiome
Mar Rodríguez, M., Pérez, D., Javier Chaves, F., Esteve, E., Marin-Garcia, P., Xifra, G., Vendrell, J., Jové, M., Pamplona, R., Ricart, W., et al. (2015) · Scientific Reports · doi:10.1038/srep14600 · Cited by 268
Alteration of the gut microbiota in Chinese population with chronic kidney disease
Jiang, S., Xie, S., Lv, D., Wang, P., He, H., Zhang, T., Zhou, Y., Lin, Q., Zhou, H., Jiang, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02989-2 · Cited by 266
Mobini, R., Tremaroli, V., Ståhlman, M., Karlsson, F., Levin, M., Ljungberg, M., Sohlin, M., Bertéus Forslund, H., Perkins, R., Bäckhed, F., et al. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12861 · Cited by 263
Xu, K.-Y., Xia, G.-H., Lu, J.-Q., Chen, M.-X., Zhen, X., Wang, S., You, C., Nie, J., Zhou, H.-W., & Yin, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-01387-y · Cited by 261
Moroti, C., Souza Magri, L. F., de Rezende Costa, M., Cavallini, D. C., & Sivieri, K. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-29 · Cited by 254
Simon, M.-C., Strassburger, K., Nowotny, B., Kolb, H., Nowotny, P., Burkart, V., Zivehe, F., Hwang, J.-H., Stehle, P., Pacini, G., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2690 · Cited by 253
Problems with the concept of gut microbiota dysbiosis
Brüssow, H. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13479 · Cited by 250
Yissachar, N., Zhou, Y., Ung, L., Lai, N. Y., Mohan, J. F., Ehrlicher, A., Weitz, D. A., Kasper, D. L., Chiu, I. M., Mathis, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.009 · Cited by 242
Lepäntalo, M., Apelqvist, J., Setacci, C., Ricco, J.-B., de Donato, G., Becker, F., Robert-Ebadi, H., Cao, P., Eckstein, H. H., De Rango, P., et al. (2011) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(11)60012-9 · Cited by 242
Complications of Diabetes 2016
Papatheodorou, K., Papanas, N., Banach, M., Papazoglou, D., & Edmonds, M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6989453 · Cited by 237
Defining the normal core microbiome of conjunctival microbial communities
Huang, Y., Yang, B., & Li, W. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.04.008 · Cited by 232
Mofidi, F., Poustchi, H., Yari, Z., Nourinayyer, B., Merat, S., Sharafkhah, M., Malekzadeh, R., & Hekmatdoost, A. (2017) · British Journal of Nutrition · doi:10.1017/s0007114517000204 · Cited by 232
Tang, W. H. W., Wang, Z., Li, X. S., Fan, Y., Li, D. S., Wu, Y., & Hazen, S. L. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.263640 · Cited by 231
Sharafedtinov, K. K., Plotnikova, O. A., Alexeeva, R. I., Sentsova, T. B., Songisepp, E., Stsepetova, J., Smidt, I., & Mikelsaar, M. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-138 · Cited by 225
Coronary Artery Disease and Diabetes Mellitus
Aronson, D., & Edelman, E. R. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.001 · Cited by 222
Dysbiosis signatures of gut microbiota in coronary artery disease
Zhu, Q., Gao, R., Zhang, Y., Pan, D., Zhu, Y., Zhang, X., Yang, R., Jiang, R., Xu, Y., & Qin, H. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00070.2018 · Cited by 221
Malik, M., Suboc, T. M., Tyagi, S., Salzman, N., Wang, J., Ying, R., Tanner, M. J., Kakarla, M., Baker, J. E., & Widlansky, M. E. (2018) · Circulation Research · doi:10.1161/circresaha.118.313565 · Cited by 219
Firouzi, S., Majid, H. A., Ismail, A., Kamaruddin, N. A., & Barakatun-Nisak, M.-Y. (2017) · European Journal of Nutrition · doi:10.1007/s00394-016-1199-8 · Cited by 216
Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects
Soleimani, A., Zarrati Mojarrad, M., Bahmani, F., Taghizadeh, M., Ramezani, M., Tajabadi-Ebrahimi, M., Jafari, P., Esmaillzadeh, A., & Asemi, Z. (2017) · Kidney International · doi:10.1016/j.kint.2016.09.040 · Cited by 213
Gut bacterial translocation is associated with microinflammation in end‐stage renal disease patients
WANG, F., JIANG, H., SHI, K., REN, Y., ZHANG, P., & CHENG, S. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01647.x · Cited by 209 · cited 1×
“In these patients, the same bacterial genus was detected in their intestines along with increased biomarkers of low-grade inflammation [43].”
BackgroundIntestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease
Sabatino, A., Regolisti, G., Cosola, C., Gesualdo, L., & Fiaccadori, E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0841-z · Cited by 200
Sabico, S., Al-Mashharawi, A., Al-Daghri, N. M., Wani, K., Amer, O. E., Hussain, D. S., Ahmed Ansari, M. G., Masoud, M. S., Alokail, M. S., & McTernan, P. G. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.009 · Cited by 200
Kobyliak, N., Falalyeyeva, T., Mykhalchyshyn, G., Kyriienko, D., & Komissarenko, I. (2018) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2018.04.015 · Cited by 196
Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction
Vaziri, N. D., Yuan, J., Nazertehrani, S., Ni, Z., & Liu, S. (2013) · American Journal of Nephrology · doi:10.1159/000353764 · Cited by 195
Lower extremity arterial disease in patients with diabetes: a contemporary narrative review
Nativel, M., Potier, L., Alexandre, L., Baillet-Blanco, L., Ducasse, E., Velho, G., Marre, M., Roussel, R., Rigalleau, V., & Mohammedi, K. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0781-1 · Cited by 194
Probiotics: How Effective Are They in the Fight against Obesity?
Mazloom, K., Siddiqi, I., & Covasa, M. (2019) · Nutrients · doi:10.3390/nu11020258 · Cited by 192
Self-citationZeng, X., Gao, X., Peng, Y., Wu, Q., Zhu, J., Tan, C., Xia, G., You, C., Xu, R., Pan, S., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00004 · Cited by 185
Blake, K. J., Baral, P., Voisin, T., Lubkin, A., Pinho-Ribeiro, F. A., Adams, K. L., Roberson, D. P., Ma, Y. C., Otto, M., Woolf, C. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02448-6 · Cited by 184
Hsieh, M.-C., Tsai, W.-H., Jheng, Y.-P., Su, S.-L., Wang, S.-Y., Lin, C.-C., Chen, Y.-H., & Chang, W.-W. (2018) · Scientific Reports · doi:10.1038/s41598-018-35014-1 · Cited by 182
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
Huang, Y., Wang, Z., Ma, H., Ji, S., Chen, Z., Cui, Z., Chen, J., & Tang, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.646348 · Cited by 180
Das, T., Jayasudha, R., Chakravarthy, S., Prashanthi, G. S., Bhargava, A., Tyagi, M., Rani, P. K., Pappuru, R. R., Sharma, S., & Shivaji, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-82538-0 · Cited by 179
ATLAS Collaboration, Asemi, Z., Samimi, M., Tabassi, Z., Naghibi Rad, M., Rahimi Foroushani, A., Khorammian, H., & Esmaillzadeh, A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.189 · Cited by 174
Emoto, T., Yamashita, T., Kobayashi, T., Sasaki, N., Hirota, Y., Hayashi, T., So, A., Kasahara, K., Yodoi, K., Matsumoto, T., et al. (2017) · Heart and Vessels · doi:10.1007/s00380-016-0841-y · Cited by 174
The impact of gut microbiota on kidney function and pathogenesis
Mahmoodpoor, F., Rahbar Saadat, Y., Barzegari, A., Ardalan, M., & Zununi Vahed, S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.066 · Cited by 172
An insight into intestinal mucosal microbiota disruption after stroke
Stanley, D., Moore, R. J., & Wong, C. H. Y. (2018) · Scientific Reports · doi:10.1038/s41598-017-18904-8 · Cited by 172
Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure
Mayerhofer, C. C. K., Ueland, T., Broch, K., Vincent, R. P., Cross, G. F., Dahl, C. P., Aukrust, P., Gullestad, L., Hov, J. R., & Trøseid, M. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.06.007 · Cited by 170
Fernandes, R., Viana, S. D., Nunes, S., & Reis, F. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.032 · Cited by 168
Razmpoosh, E., Javadi, A., Ejtahed, H. S., Mirmiran, P., Javadi, M., & Yousefinejad, A. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2018.08.008 · Cited by 167
Karamali, M., Dadkhah, F., Sadrkhanlou, M., Jamilian, M., Ahmadi, S., Tajabadi-Ebrahimi, M., Jafari, P., & Asemi, Z. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.04.009 · Cited by 166
Bacterial Signaling to the Nervous System through Toxins and Metabolites
Yang, N. J., & Chiu, I. M. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.12.023 · Cited by 165
Nie, J., Xie, L., Zhao, B.-X., Li, Y., Qiu, B., Zhu, F., Li, G.-F., He, M., Wang, Y., Wang, B., et al. (2018) · Stroke · doi:10.1161/strokeaha.118.021997 · Cited by 163
Lee, C. B., Chae, S. U., Jo, S. J., Jerng, U. M., & Bae, S. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073566 · Cited by 163
Probiotics to Adolescents With Obesity
Gøbel, R. J., Larsen, N., Jakobsen, M., Mølgaard, C., & Michaelsen, K. F. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318263066c · Cited by 160
ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy
Verma, A., Shan, Z., Lei, B., Yuan, L., Liu, X., Nakagawa, T., Grant, M. B., Lewin, A. S., Hauswirth, W. W., Raizada, M. K., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.155 · Cited by 159
Khalili, L., Alipour, B., Jafarabadi, M. A., Faraji, I., Hassanalilou, T., Abbasi, M. M., Vaghef‐Mehrabany, E., & Sani, M. A. (2018) · Iranian Biomedical Journal · doi:10.29252/ibj.23.1.68 · Cited by 159
Lindsay, K. L., Kennelly, M., Culliton, M., Smith, T., Maguire, O. C., Shanahan, F., Brennan, L., & McAuliffe, F. M. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.079723 · Cited by 158
Overview of Newer Agents: Where Treatment Is Going
DeFronzo, R. A. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.008 · Cited by 158
Kanbay, M., Onal, E. M., Afşar, B., Dağel, T., Yerlikaya, A., Covic, A. C., & Vaziri, N. D. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1873-2 · Cited by 158
Palacios, T., Vitetta, L., Coulson, S., Madigan, C. D., Lam, Y. Y., Manuel, R., Briskey, D. R., Hendy, C., Kim, J.-N., Ishoey, T., et al. (2020) · Nutrients · doi:10.3390/nu12072041 · Cited by 158
Evaluation of wound healing activities of kefir products
Huseini, H. F., Rahimzadeh, G., Fazeli, M. R., Mehrazma, M., & Salehi, M. (2012) · Burns · doi:10.1016/j.burns.2011.12.005 · Cited by 157
Mohseni, S., Bayani, M., Bahmani, F., Ebrahimi, M. T., Bayani, M. A., Jafari, P., & Asemi, Z. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2970 · Cited by 154
Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy
Lin, B., Wang, Y., Zhang, P., Yuan, Y., Zhang, Y., & Chen, G. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01170-x · Cited by 149
Takayama, F., Taki, K., & Niwa, T. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50104 · Cited by 146
Shakeri, H., Hadaegh, H., Abedi, F., Tajabadi‐Ebrahimi, M., Mazroii, N., Ghandi, Y., & Asemi, Z. (2014) · Lipids · doi:10.1007/s11745-014-3901-z · Cited by 145
Association Study of Gut Flora in Coronary Heart Disease through High-Throughput Sequencing
Cui, L., Zhao, T., Hu, H., Zhang, W., & Hua, X. (2017) · BioMed Research International · doi:10.1155/2017/3796359 · Cited by 145
Simenhoff, M. L., Dunn, S., Zollner, G. P., Fitzpatrick, M. E., Emery, S. M., Sandine, W. E., & Ayres, J. W. (1996) · PubMed · Cited by 143
Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats
Lam, V., Su, J., Hsu, A., Gross, G. J., Salzman, N. H., & Baker, J. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160840 · Cited by 143
Effect of probiotics on human blood urea levels in patients with chronic renal failure.
Miranda-Alatriste, P., Arronte, R. U., Espinosa, C. O. G., & Espinosa-Cuevas, Á. (2014) · PubMed · doi:10.3305/nh.2014.29.3.7179 · Cited by 142
Jung, S.-P., Lee, K.-M., Kang, J.-H., Yun, S.-I., Park, H.-O., Moon, Y., & Kim, J.-Y. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.2.80 · Cited by 140
Biogeography of the human ocular microbiota
Ozkan, J., Willcox, M. D. P., Wemheuer, B., Wilcsek, G., Coroneo, M. T., & Thomas, T. (2018) · The Ocular Surface · doi:10.1016/j.jtos.2018.11.005 · Cited by 140
Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol
Simons, L. A., Amansec, S. G., & Conway, P. L. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.009 · Cited by 138
Eslamparast, T., Zamani, F., Hekmatdoost, A., Sharafkhah, M., Eghtesad, S., Malekzadeh, R., & Poustchi, H. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000919 · Cited by 133
Ranganathan, N., Friedman, E. A., Tam, P. Y., Rao, V. G., Ranganathan, P., & Dheer, R. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903069249 · Cited by 133
Madjd, A., Taylor, M. A., Mousavi, N., Delavari, A., Malekzadeh, R., Macdonald, I. A., & Farshchi, H. R. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.120170 · Cited by 131
Rajkumar, H., Kumar, M., Das, N., Kumar, S. N., Challa, H. R., & Nagpal, R. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414555004 · Cited by 128
Sabico, S., Al-Mashharawi, A., Al‐Daghri, N. M., Yakout, S. M., Alnaami, A. M., Alokail, M. S., & McTernan, P. G. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1354-x · Cited by 128
Increased plasma trimethylamine- N -oxide is associated with incident atrial fibrillation
Svingen, G. F. T., Zuo, H., Ueland, P. M., Seifert, R., Løland, K. H., Pedersen, E. R., Schuster, P. M., Karlsson, T. R., Tell, G. S., Schartum-Hansen, H., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.04.128 · Cited by 127
Boyko, E. J., Seelig, A. D., & Ahroni, J. H. (2018) · Diabetes Care · doi:10.2337/dc17-2210 · Cited by 125
Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes
Mohammad-Shahi, M., Veissi, M., Haidari, F., Shahbazian, H. B., Kaydani, G. A., & Mohammadi, F. (2014) · Europe PMC (PubMed Central) · doi:10.5681/bi.2014.007 · Cited by 124
Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
Covașă, M., Stephens, R. W., Toderean, R., & Cobuz, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00082 · Cited by 124
Shavakhi, A., Minakari, M., Firouzian, H., Assali, R., Hekmatdoost, A., & Ferns, G. A. (2013) · PubMed Central · Cited by 123
Raygan, F., Rezavandi, Z., Bahmani, F., Ostadmohammadi, V., Mansournia, M. A., Ebrahimi, M. T., Borzabadi, S., & Asemi, Z. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0353-2 · Cited by 123
Ebrahimi, M. T., Sharifi, N., Farrokhian, A., Raygan, F., Karamali, F., Razzaghi, R., Taheri, S., & Asemi, Z. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-105441 · Cited by 122
Nephropathy in type 2 diabetes
Ritz, E. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00411.x · Cited by 118
Mafi, A., Namazi, G., Soleimani, A., Bahmani, F., Aghadavod, E., & Asemi, Z. (2018) · Food & Function · doi:10.1039/c8fo00888d · Cited by 116
Kumari, M., Singh, P., Nataraj, B. H., Kokkiligadda, A., Naithani, H., Ali, S. A., Behare, P. V., & Nagpal, R. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110716 · Cited by 116
Human Microbiota and Ophthalmic Disease.
Lu, L. J., & Liu, J. (2016) · PubMed Central · Cited by 115
Raygan, F., Ostadmohammadi, V., Bahmani, F., & Asemi, Z. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.02.007 · Cited by 112
Miraghajani, M. S., Zaghian, N., Mirlohi, M., Feizi, A., & Ghiasvand, R. (2017) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2017.04.004 · Cited by 110
Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice
Verma, A., Xu, K., Du, T., Zhu, P., Liang, Z., Liao, S., Zhang, J., Raizada, M. K., Grant, M. B., & Li, Q. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.06.007 · Cited by 104
Madempudi, R. S., Ahire, J. J., Neelamraju, J., Tripathi, A., & Nanal, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225168 · Cited by 104
Gut mycobiomes are altered in people with type 2 Diabetes Mellitus and Diabetic Retinopathy
Jayasudha, R., Das, T., Chakravarthy, S. K., Prashanthi, G. S., Bhargava, A., Tyagi, M., Rani, P. K., Pappuru, R. R., & Shivaji, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243077 · Cited by 102
Kassaian, N., Feizi, A., Aminorroaya, A., Jafari, P., Ebrahimi, M. T., & Amini, M. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1175-2 · Cited by 100
Ivey, K. L., Hodgson, J. M., Kerr, D. A., Lewis, J. R., Thompson, P. L., & Prince, R. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.294 · Cited by 98
Gourgari, E., Wilhelm, E. E., Hassanzadeh, H. R., Aroda, V. R., & Shoulson, I. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.08.005 · Cited by 98
Wang, Y., Ye, X., Ding, D., & Lu, Y. (2020) · Journal of International Medical Research · doi:10.1177/0300060520936806 · Cited by 98
Microbiota: a novel regulator of pain
Defaye, M., Gervason, S., Altier, C., Berthon, J., Ardid, D., Filaire, E., & Carvalho, F. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02083-z · Cited by 87
Effects of a Symbiotic on Gut Microbiota in Mexican Patients With End-Stage Renal Disease
Cruz-Mora, J., Martínez-Hernández, N. E., Martín-del-Campo, F., Hörner, D. V., Vizmanos-Lamotte, B., Muñóz-Valle, J. F., García-García, G., Parra‐Rojas, I., & Castro-Alarcón, N. (2014) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2014.05.006 · Cited by 84
Arani, N. M., Emam‐Djomeh, Z., Tavakolipour, H., Chaleshtori, R. S., Soleimani, A., & Asemi, Z. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9468-x · Cited by 84
McMullan, C. J., Heerspink, H. J. L., Parving, H., Dwyer, J. P., Forman, J. P., & de Zeeuw, D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.06.008 · Cited by 78
Ogawa, A., Kadooka, Y., Kato, K., Shirouchi, B., & Sato, M. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-36 · Cited by 75
Miraghajani, M. S., Zaghian, N., Dehkohneh, A., Mirlohi, M., & Ghiasvand, R. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9325-3 · Cited by 73
Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy
Rolim, L. C., da Silva, E. M., Flumignan, R. L., Abreu, M. M., & Dib, S. A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011265.pub2 · Cited by 71
Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes
Mardinoğlu, A., Borén, J., & Smith, U. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.012 · Cited by 70
Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy
Liu, W., Wang, C., Xia, Y., Xia, W. T., Liu, G., Ren, C., Gu, Y., Li, X., & Lu, P. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01610-9 · Cited by 69
Diabetic Retinopathy: Battling the Global Epidemic
Das, A. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-21031 · Cited by 68
The Profile and Function of Gut Microbiota in Diabetic Nephropathy
Chen, W., Zhang, M., Guo, Y. H., Wang, Z., Liu, Q., Yan, R., Wang, Y., Wu, Q., Yuan, K., & Sun, W. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s320169 · Cited by 67
Akhoundzadeh, K., Vakili, A., Shadnoush, M., & Sadeghzadeh, J. (2018) · PubMed Central · Cited by 65
Jones, M. L., Martoni, C. J., Di Pietro, E., Simon, R. R., & Prakash, S. (2012) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2012.04.003 · Cited by 64
The gut microbiota to the brain axis in the metabolic control
Grasset, E., & Burcelin, R. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09511-1 · Cited by 63
Kullisaar, T., Zilmer, K., Salum, T., Rehema, A., & Zilmer, M. (2016) · Nutrition Journal · doi:10.1186/s12937-016-0213-6 · Cited by 59
Gourgari, E., Dabelea, D., & Rother, K. I. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0968-y · Cited by 59
Dominguez, J. M., Hu, P., Caballero, S., Moldovan, L., Verma, A., Oudit, G. Y., Li, Q., & Grant, M. B. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.01.023 · Cited by 57
Karadurmuş, N., Şahin, M., Taşçı, C., Naharci, I., Öztürk, C., Ilbasmis, S., Dulkadir, Z., Şen, A., & Sağlam, K. (2010) · PubMed · Cited by 54
Sonal Sekhar, M., Unnikrishnan, M. K., Vijayanarayana, K., Rodrigues, G. S., & Mukhopadhyay, C. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2013.11.013 · Cited by 52
Taghizadeh, M., & Asemi, Z. (2014) · HORMONES · doi:10.14310/horm.2002.1489 · Cited by 50
Dunn, S., Simenhoff, M. L., Ahmed, K. E., Gaughan, W. J., Eltayeb, B. O., Fitzpatrick, M.-E. D., Emery, S. M., Ayres, J. W., & Holt, K. E. (1998) · International Dairy Journal · doi:10.1016/s0958-6946(98)00081-8 · Cited by 48
Sjolie, A.-K., Dodson, P. M., & Hobbs, R. F. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02552.x · Cited by 46
Baig, M. A., & Panchal, S. S. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190411115829 · Cited by 45
Abbasi, B., Ghiasvand, R., & Mirlohi, M. (2017) · Iranian Journal of Kidney Diseases · Cited by 43
Yamashiro, K., Tanaka, R., Urabe, T., Ueno, Y., Yamashiro, Y., Nomoto, K., Takahashi, T., Tsuji, H., Asahara, T., & Hattori, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176062 · Cited by 43
Rigobelo, E. C. (2012) · InTech eBooks · doi:10.5772/3444 · Cited by 38
Diabetes Complications and the Renin–Angiotensin System
Perkins, B. A., Aiello, L. P., & Królewski, A. S. (2009) · New England Journal of Medicine · doi:10.1056/nejme0904293 · Cited by 30
Intestinal bacteria-derived putrefactants in chronic renal failure
Fukuuchi, F., Hida, M., Aiba, Y., Koga, Y., Endoh, M., Kurokawa, K., & Sakai, H. (2002) · Clinical and Experimental Nephrology · doi:10.1007/s101570200016 · Cited by 30
Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
Lee, S. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.1.36 · Cited by 27
Bekyarova, G. Y., Ivanova, D. G., & Madjova, V. (2007) · PubMed · Cited by 25
Fialho, A., Fialho, A. B. C., Kochhar, G. S., Schenone, A. L., Thota, P. N., McCullough, A. J., & Shen, B. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4828-z · Cited by 25
Heianza, Y., Sun, D., Ma, W., Zheng, Y., Champagne, C. M., Bray, G. A., Sacks, F. M., & Qi, L. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0046-9 · Cited by 24
In This Issue: Immunology of the Eye—Inside and Out
Caspi, R. R. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2012.750138 · Cited by 20
[Gut microbiota, responsible for our body weight?].
Pataky, Z., Bobbioni-Harsch, E., Hadengue, A., Carpentier, A., & Golay, A. (2009) · PubMed · Cited by 16
Research works printed but not linked: 7
- Kowalewska, 2016, Higher diversity in fungal species discriminates children with type 1 diabetes mellitus from healthy control, Patient Prefer. Adherence, 10, 591
- Gupta, 2011, Targeted therapies in diabetic nephropathy: An update, J. Nephrol., 24, 686, 10.5301/jn.5000041 · doi:10.5301/jn.5000041
- Jeganathan, 2011, The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy, Curr. Pharm. Biotechnol., 12, 392, 10.2174/138920111794480615 · doi:10.2174/138920111794480615
- LI, 2018, Recombinant Probiotics Expressing Angiotensin-(1-7) Improves Glucose Metabolism and Diabetes-Induced Renal and Retinal Injury, Diabetes, 67, 33-LB, 10.2337/db18-33-LB · doi:10.2337/db18-33-lb
- George, 2020, Effects of Probiotic on the Development of Diabetic Retinopathy, Investig. Ophthalmol. Vis. Sci., 61, 4961
- Sawacha, 2010, A New Classification of Diabetic Gait Pattern Based on Cluster Analysis of Biomechanical Data, J. Diabetes Sci. Technol., 4, 1127, 10.1177/193229681000400511 · doi:10.1177/193229681000400511
- Bjerg, 2015, Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8(R) shows modest effect on triacylglycerol in young healthy adults, Benef. Microbes., 6, 29, 10.3920/BM2014.0058 · DOI
Cited by
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
NF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S.-C. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 489
Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications
Akpoveso, O.-O. P., Ubah, E. E., & Obasanmi, G. (2023) · Antioxidants · doi:10.3390/antiox12010123 · Cited by 90
Diabetes and its complications: molecular mechanisms, prevention and treatment
Zhao, L., Yuan, J., Yang, Q., Ma, J., Yang, F., Zou, Y., Liu, K., & Liu, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02401-w · Cited by 80
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Metadata
- Authors
- Iatcu, C. O., Steen, A., & Covasa, M.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-12-30
- Volume
- 14
- Issue
- 1
- Pages
- 166
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W4206445672
- Cited by
- 418
- References
- 172
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- European Regional Development Fund through Competitiveness Operational Program (120/16.09.2016.)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.